Niki Karachaliou
Merck (Germany)(DE)Institut für Urheber- und Medienrecht(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Non-small-cell lung cancer(2015)1,068 cited
- → The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies(2015)552 cited
- → Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry(2017)353 cited
- → Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets(2017)321 cited
- → Genetics and biomarkers in personalisation of lung cancer treatment(2013)316 cited
- → Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification(2018)304 cited
- → RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer(2015)276 cited
- → Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients(2018)269 cited
- → Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial(2015)235 cited
- → KRAS Mutations in Lung Cancer(2012)227 cited